Drugs / cetrolix
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT05071339 | Apr 2021 → Mar 2023 | — | Assaf-Harofeh Medical Center | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | cetrolix | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05071339 ↗ |
| Known as | Cetrotide | “Cetrotide (cetrolix) or Orgalutran (ganirelix) - depending on their primary prescription” NCT05071339 ↗ |